{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:15:28Z","timestamp":1776348928095,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/01892"],"award-info":[{"award-number":["PI22\/01892"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/00920"],"award-info":[{"award-number":["PI21\/00920"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PMP22\/00054"],"award-info":[{"award-number":["PMP22\/00054"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"Biomedical Research Network Centre in Cancer","doi-asserted-by":"publisher","award":["CB16\/12\/00398"],"award-info":[{"award-number":["CB16\/12\/00398"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"Biomedical Research Network Centre in Cancer","doi-asserted-by":"publisher","award":["CB16\/12\/00316"],"award-info":[{"award-number":["CB16\/12\/00316"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Spanish Association Against Cancer Scientific Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijgc.2026.104563","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:36:31Z","timestamp":1770424591000},"page":"104563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinoma"],"prefix":"10.1016","volume":"36","author":[{"given":"Esther","family":"Moreno-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9302-9519","authenticated-orcid":false,"given":"Tamara","family":"Caniego-Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Ruz-Caracuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-2965","authenticated-orcid":false,"given":"Irene","family":"Carretero-Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5140-2892","authenticated-orcid":false,"given":"Elena","family":"Cabezas-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-7583","authenticated-orcid":false,"given":"Alfonso","family":"Cort\u00e9s-Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mendiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7257-5642","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4805-4011","authenticated-orcid":false,"given":"Alfonso","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2183-3699","authenticated-orcid":false,"given":"David","family":"Hardisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6730-5066","authenticated-orcid":false,"given":"Jos\u00e9","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5764-5182","authenticated-orcid":false,"given":"Bel\u00e9n","family":"P\u00e9rez-Mies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijgc.2026.104563_bib1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3390\/cancers11121845","article-title":"Myoinvasive pattern as a prognostic marker in low-grade, early-stage endometrioid endometrial carcinoma","volume":"11","author":"Ruz-Caracuel","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104563_bib2","first-page":"13","article-title":"Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma","volume":"59","author":"Am\u0103linei","year":"2018","journal-title":"Rom J Morphol Embryol"},{"issue":"22","key":"10.1016\/j.ijgc.2026.104563_bib3","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.3390\/cancers13225848","article-title":"Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification","volume":"13","author":"Kasius","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104563_bib4","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cancers13112623","article-title":"New pathological and clinical insights in endometrial cancer in view of the updated ESGO\/ESTRO\/ESP guidelines","volume":"13","author":"Santoro","year":"2021","journal-title":"Cancers"},{"issue":"7447","key":"10.1016\/j.ijgc.2026.104563_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104563_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.path.2022.02.006","article-title":"Endometrial cancer: an update on prognostic pathologic features and clinically relevant biomarkers","volume":"15","author":"Li","year":"2022","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104563_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104563_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104563_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijgc.2026.104563_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3332\/ecancer.2020.1061","article-title":"Clinicopathologic features of endometrial cancer with mismatch repair deficiency","volume":"14","author":"Gordhandas","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104563_bib11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/cancers13050950","article-title":"ARID1A and CTNNB1\/\u03b2-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: implications for an improved surrogate molecular classification","volume":"13","author":"De","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104563_bib12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/jnci\/djac119","article-title":"Genomic determinants of early recurrences in low-stage, low-grade endometrioid endometrial carcinoma","volume":"114","author":"Safdar","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104563_bib13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/s41379-022-01066-y","article-title":"Genomic landscape of endometrial carcinomas of no specific molecular profile","volume":"35","author":"Momeni-Boroujeni","year":"2022","journal-title":"Mod Pathol"},{"issue":"23","key":"10.1016\/j.ijgc.2026.104563_bib14","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1158\/1078-0432.CCR-17-0566","article-title":"Amplification of 1q32.1 refines the molecular classification of endometrial carcinoma","volume":"23","author":"Depreeuw","year":"2017","journal-title":"Clin Cancer Res."},{"issue":"22","key":"10.1016\/j.ijgc.2026.104563_bib15","first-page":"11528","article-title":"MDM4 is targeted by miR-449b-5p to promote the proliferation of endometrial carcinoma","volume":"24","author":"Zhao","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104563_bib16","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1007\/s13277-016-4940-2","article-title":"The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer","volume":"37","author":"Gansmo","year":"2016","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104563_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00428-021-03176-5","article-title":"Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma","volume":"479","author":"Ruz-Caracuel","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ijgc.2026.104563_bib18","series-title":"Female Genital Tumours: WHO Classification of Tumours","year":"2020"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104563_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAP.0b013e31828d17cc","article-title":"Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications","volume":"20","author":"Cole","year":"2013","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104563_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/his.13871","article-title":"Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer","volume":"75","author":"Peters","year":"2019","journal-title":"Histopathology"},{"issue":"45","key":"10.1016\/j.ijgc.2026.104563_bib21","doi-asserted-by":"crossref","first-page":"27728","DOI":"10.18632\/oncotarget.25543","article-title":"Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma","volume":"9","author":"Yoshioka","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104563_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104563_bib23","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1158\/2159-8290.CD-23-0546","article-title":"Molecular characterization of endometrial carcinomas in black and white patients reveals disparate drivers with therapeutic implications","volume":"13","author":"Weigelt","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijgc.2026.104563_bib24","article-title":"Oncogene-like addiction to aneuploidy in human cancers","volume":"2023","author":"Girish","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijgc.2026.104563_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-030-35727-6_6","article-title":"Necrosis in the tumor microenvironment and its role in cancer recurrence","volume":"1225","author":"Karsch-Bluman","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104563_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/ijgc-2020-001241","article-title":"Clinical patterns and genomic profiling of recurrent \u201cultra-low risk\u201d endometrial cancer","volume":"30","author":"Stasenko","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104563_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PAI.0000000000001102","article-title":"Estrogen\/progesterone receptor loss, CTNNB1 and KRAS mutations are associated with local recurrence or distant metastasis in low-grade endometrial endometrioid carcinoma","volume":"31","author":"Chibbar","year":"2023","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ijgc.2026.104563_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2023.04.018","article-title":"Adjuvant radiation therapy in early-stage endometrial cancer with abnormal beta-catenin expression is associated with improved local control","volume":"174","author":"Hui","year":"2023","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:30:48Z","timestamp":1776346248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1048891X26000952"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104563","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"104563"}}